参考文献/References:
[1]Lewington S,Lacey B,Clarke R,et al.The Burden of Hypertension and Associated Risk for Cardiovascular Mortality in China[J].JAMA Internal Medicine,2016,176(4):524-532. [2]Wang Z,Chen Z,Zhang L,et al.Status of Hypertension in China:Results from the ChinaHypertension Survey,2012-2015[J].Circulation,2018,137(22):2344-2356. [3]《中国高血压防治指南》修订委员会.中国高血压防治指南2018年修订版[J].心脑血管病防治,2019,19(1):6-49. [4]中华人民共和国国家卫生和计划生育委员会.成人体重判定:WS/T 428-2013[S].北京:中国标准出版社,2013. [5]王增武,郝光,王馨,等.我国中年人群超重/肥胖现况及心血管病危险因素聚集分析[J].中华流行病学杂志,2014,35(4):354-358. [6] 中国成人血脂异常防治指南修订联合委员会.中国成人血脂异常防治指南(2016年修订版)[J].中国循环杂志,2016,31(10):937-950. [7]张明香.酒精性肝病的诊断与治疗[C]//全国疑难及重症肝病大会.2017. [8]袁姣,武青松,雷枢,等.我国中老年人群高血压流行现状及影响因素研究[J].中国全科医学,2020,23(34):4337-4341. [9]Hu L,Huang X,You C,et al.Prevalence and Risk Factors of Prehypertension and Hypertension in Southern China[J].PLoS One,2017,12(1):e0170238. [10]Shen Y,Chang C,Zhang J.Prevalence and risk factors associated with hypertension and prehypertension in a working population at high altitude in China:a cross-sectional study[J]. Environ Health Prev Med,2017,22(1):19. [11]马斐,杨会萍,任骞.老年冠心病合并高血压患者收缩压J形曲线与不良心脑血管事件关系[J].中国循证心血管医学杂志,2017,9(2):225-227. [12]刘青,刘莉,Lee H,et al.青年人群单纯收缩期或舒张期高血压的心血管病风险[J].中华高血压杂志,2020,28(8):703. [13]Yang L,Yan J,Tang X,et al.Prevalence,Awareness,Treatment,Control and Risk Factors Associated with Hypertension among Adults in Southern China,2013[J].PLoS One,2016,11(1):e0146181. [14]张秀芬,郝海水.老年高血压病患者血压与血脂和血糖以及脂肪肝的关系探究[J].实用心脑肺血管病杂志,2019,v.27(S1):128-130. [15]Yang G,Ma Y,Wang S,et al.Prevalence and Correlates of Prehypertension and Hypertension among Adults in Northeastern China:A Cross-Sectional Study[J].International Journal of Environmental Research&Public Health,2015,13(1):82. [16]张业.脂肪肝与高血压病、高血脂症、糖尿病以及BMI相关性分析[J].泰山医学院学报,2019,40(5):379-381. [17]苏振华.体质量指数及血脂,尿酸,血糖水平与高血压的相关性[J].医疗装备,2020,33(5):61-62. [18]Zhang Y,Moran AE.Trends in the Prevalence, Awareness,Treatment,and Control of Hypertension Among Young Adults in the United States,1999 to 2014[J].Hypertension,2017,70(4):736-742. [19]王淳秀,吴晓光,刘宏军,等.北京市2013-2014年15岁及以上居民高血压患病率,知晓率,治疗率和控制率调查[J].中华流行病学杂志,2018(2):179-183.
相似文献/References:
[1]颜 明,龚丽娜,王淑清.彩超在高血压患者肾动脉血流动力学检测中的应用分析[J].医学信息,2018,31(02):156.[doi:10.3969/j.issn.1006-1959.2018.02.060]
YAN Ming,GONG Li-na,WANG Shu-qing.Application of Color Doppler Ultrasound in the Measurement of Renal Artery Hemodynamics in Patients with Hypertension[J].Medical Information,2018,31(06):156.[doi:10.3969/j.issn.1006-1959.2018.02.060]
[2]夏能能,任 薇,杜建平,等.1953~2016年中医药治疗高血压领域研究热点分析[J].医学信息,2018,31(04):18.[doi:10.3969/j.issn.1006-1959.2018.04.007]
XIA Neng-neng,REN Wei,DU Jian-ping,et al.Analysis of Hot Spots in the Research of Traditional Chinese Medicine in Treating Hypertension from 1953 to 2016[J].Medical Information,2018,31(06):18.[doi:10.3969/j.issn.1006-1959.2018.04.007]
[3]靳雪芹,邓正聪.代谢综合征与肿瘤关系的研究进展[J].医学信息,2018,31(05):35.[doi:10.3969/j.issn.1006-1959.2018.05.014]
JIN Xue-qin,DENG Zheng-cong.Research Progress on the Relationship between Metabolic Syndrome and Tumor[J].Medical Information,2018,31(06):35.[doi:10.3969/j.issn.1006-1959.2018.05.014]
[4]乔 君,高 翔,王 瑜,等.缬沙坦对原发性高血压患者外周PBMC中IL-17表达的影响[J].医学信息,2018,31(07):65.[doi:10.3969/j.issn.1006-1959.2018.07.021]
QIAO Jun,GAO Xiang,WANG Yu,et al.The Effect of Valsartan on the Expression of IL-17 in Peripheral PBMC of Patients with Essential Hypertension[J].Medical Information,2018,31(06):65.[doi:10.3969/j.issn.1006-1959.2018.07.021]
[5]董巧玲.健康教育对原发性高血压患者治疗效果的影响[J].医学信息,2018,31(09):180.[doi:10.3969/j.issn.1006-1959.2018.09.060]
DONG Qiao-ling.Effect of Health Education on Treatment of Patients with Essential Hypertension[J].Medical Information,2018,31(06):180.[doi:10.3969/j.issn.1006-1959.2018.09.060]
[6]汤海霞,班 涛.大黄素与心血管疾病的研究[J].医学信息,2022,35(11):19.[doi:10.3969/j.issn.1006-1959.2022.11.006]
TANG Hai-xia,BAN Tao.Research on Emodin and Cardiovascular Diseases[J].Medical Information,2022,35(06):19.[doi:10.3969/j.issn.1006-1959.2022.11.006]
[7]沈 正,王庆海.焦虑抑郁障碍与血压变异性研究[J].医学信息,2018,31(16):34.[doi:10.3969/j.issn.1006-1959.2018.16.010]
SHEN Zheng,WANG Qing-hai.Study on Anxiety and Depression Disorder and Blood Pressure Variability[J].Medical Information,2018,31(06):34.[doi:10.3969/j.issn.1006-1959.2018.16.010]
[8]左洪亮.苯磺酸左旋氨氯地平片治疗中老年患者
轻中度原发性高血压的疗效观察[J].医学信息,2018,31(16):120.[doi:10.3969/j.issn.1006-1959.2018.16.037]
ZUO Hong-liang.Efficacy of Levamlodipine Besylate Tablets in Treatment of Mild to Moderate Essential Hypertension in Middle-aged and Elderly Patients[J].Medical Information,2018,31(06):120.[doi:10.3969/j.issn.1006-1959.2018.16.037]
[9]袁 敏,周袁成.钙离子拮抗剂类降压药的临床应用与不良反应分析[J].医学信息,2018,31(17):125.[doi:10.3969/j.issn.1006-1959.2018.17.038]
YUAN Min,ZHOU Yuan-cheng.Clinical Application and Adverse Reaction Analysis of Calcium Antagonist Antihypertensive Drugs[J].Medical Information,2018,31(06):125.[doi:10.3969/j.issn.1006-1959.2018.17.038]
[10]陈学军,李 敏,张 丹,等.社区一体化分级管理模式对社区老年高血压患者的管理效果[J].医学信息,2018,31(18):169.[doi:10.3969/j.issn.1006-1959.2018.18.055]
CHEN Xue-jun,LI Min,ZHANG Dan,et al.Management Effect of Community Integration Hierarchical Management Mode on Elderly Hypertensive Patients in Community[J].Medical Information,2018,31(06):169.[doi:10.3969/j.issn.1006-1959.2018.18.055]